• |
  • |
  • |
  • |
Donate

Project

PHARM -- A Phase III Randomized Double-Blind Placebo-Controlled Trial of CM-AT in Children with Autism

Center:
Fiscal Year:
2011
Contact Information:
Project Description:
This study examines the effects of supplementation with a digestive enzyme on autism symptoms and gastrointestinal distress.
Keyword(s):
autism, gastrointestinal distress, chymotrypsin
Core Function(s):
Performing Research or Evaluation
Area of Emphasis
Health-Related Activities
Target Audience:
Children/Adolescents with Disabilities/SHCN
Unserved or Under-served Populations:
Specific Groups
Primary Target Audience Geographic Descriptor:
National
Funding Source:
COVID-19 Related Data:
N/A